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1. Introduction 
0-methyl-threonine and thiaisoleucine (2-amino-3- 
methyl-thiobutyrate) are two analogues of isoleucine 
which inhibit the growth of Escherichia coli: O-methyl- 
threonine inhibition is reversed by isoleucine, valine 
and leucine [l] while thiaisoleucine inhibition is re- 
versed by isoleucine alone [2]. It has been suggested 
that these two substances might inhibit the growth of 
E. coli in different ways: they might interfere with the 
active transport of isoleucine into the cell, compete 
with isoleucine for incorporation into proteins, cause 
a “false repression” of “false feedback inhibition” 
[ 1,2]. These two substances also inhibit the activity 
of the enzyme threonine deaminase: inhibition of 
threonine deaminase by 0-methyl-threonine in crude 
extracts of E. coli 15 has been reported by Smulson 
et al. [l] while inhibition of threonine deaminase by 
thiaisoleucine in crude extracts of E. coli K- 12 has 
been reported by Szentirmai and Umbarger [2]. This 
inhibition might be a consequence of the similarity in 
structure between 0-methyl-threonine thiaisoleucine 
and isoleucine (see table 1). since it has been reported 
[3,4] that the latter substance is an allosteric inhibitor 
of threonine deaminase. It is not possible, however, to 
conclude from the available data if these two analogues 
interact with threonine deaminase at the allosteric site 
(and thus behave as isoleucine analogues of “false feed- 
back” inhibitors) or at the catalytic site (in which case 
they should be considered threonine analogues). 
Since “false feedback” inhibitors are useful analo- 
gues to be used in the search for regulatory mutants 
and, since such inhibitors are not known in the case of 
isoleucine biosynthesis, we decided to test the effect 
of these two analogues on the activity of threonine 
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deaminase (L-threonine-hydrolase (deaminating) EC 
4.2.1.16) purified from E. coli K-12. This allosteric 
[5] enzyme is the first enzyme in isoleucine biosyn- 
thesis (see table 1); its allosteric inhibitor is isoleucine 
while valine is an allosteric activator. In this report we 
illustrate experiments on the mechanism of inhibition 
of threonine deaminase by 0-methyl-threonine and 
thiaisoleucine. 
2. Materials and methods 
2.1. Reagents 
Amino acids used were all L-form of the highest 
purity available. Uridine was purchased from Sigma. 
Thiamine hydrochloride, dithiothreitol (Cleland’s 
reagent) and pyridoxal phosphate were purchased 
from Calbiochem. NADH and lactate dehydrogenase 
Table 1 
Isoleucine biosynthetic pathway and the structure of O-methyl- 
threonine and thiaisoleucine. 
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were obtained from Boehringer Mannheim GmbH, 
DEAE-cellulose and hydroxylapatite were products of 
Bio Rad. Thiaisoleucine hydrochloride (2-amino-3- 
methyl-thiobutyrate) and 0-methyl-DL-threonine 
were obtained from Reef Laboratories, Santa Paula, 
Calif. It is not known if thiaisoleucine is a racemic 
form [2]. All other chemicals were reagent grade, and 
quartz-redistilled water was used for all solutions. 
2.2. Bacterial strain and culture conditions 
Threonine deaminase was purified as described in 
the next section from a derivative of E. coli K-12, 
strain M1164, a HfrH bearing the following chromoso- 
mal markers: pyrA.53, thi-I, (A); ileS1, ilv0. The prep- 
aration of this strain has been described by Iaccarino 
and Berg [6]: it is a Thr+ transductant (isolate no. 18) 
of strain AW206 transduced with a Pl phage grown on 
strain MI1 (ileN, thr+). Strain MI164 still contains the 
ilv0 mutation of AW206 but has now also an altered 
isoleucyl-tRNA synthetase activity due to the presence 
of the ileS1 mutation; as a consequence of the presence 
of these two mutations threonine deaminase is more 
derepressed than in either AW206 or MI 1. 
Strain MI 164 was grown in the minimal medium 
described by Vogel and Bonner [7] supplemented with 
100 mg/l of L-arginine, 100 mg/l of L-isoleucine, 50 
mg/l of uridine, 10 mg/l of thiamine hydrochloride and 
50 mg/l of L-leucine. Leucine was added because, as 
described by Guardiola and Iaccarino [8], we usually 
observe a 2- to 3-fold derepression of threonine dea- 
minase upon addition of leucine to the minimal medi- 
um. 
Typical specific activities (see sect. 2.3) of extracts 
were 0.046 for wild type, 0.480 or 1.09 for strain 
MI164 grown, respectively, in minimal medium with 
no leucine added or in minimal medium supplemented 
with leucine. Our initial extracts, therefore, are about 
24-fold derepressed as compared to wild type. 
2.3. Enzyme assay 
Threonine deamination in crude extracts was assay- 
ed by measuring the rate of formation of ar-ketobutyr- 
ate as described by Iaccarino and Berg [6]. Rate stu- 
dies with the partially purified enzyme were perform- 
ed by the use of the coupled assay of Maeba and San- 
wal [9] in a final volume of 0.8 ml. In this assay mix- 
ture, containing an excess lactate dehydrogenase, the 
cY-ketobutyrate produced in the threonine deaminase 
Table 2 
Purification of threonine deaminase from E. coli K-12. 
Total Total Specific 
Volume activity proteins activity Yield 
(ml) (units) (mg) (unitslmg) (%) 
Extract 56 3320 3046 1.09 100 
DEAE- 
cellulose 260 1370 135.2 10.0 41 
Hydroxyl- 
apatite 12 686 11.3 60.8 21 
reaction oxidizes NADH and the rate of oxidation, 
measured spectrophotometrically at 340 nm, is pro- 
portional to the amount of threonine deaminase added. 
The reaction was started by addition of enzyme. 
A unit of enzyme activity is defined as the amount 
of enzyme forming at 22” 1 nmole of o-ketobutyrate 
per minute. Specific activities are units per mg of pro- 
tein. Proteins were determined by the method of 
Groves [lo] with crystalline bovine serum albumin as 
a standard. 
2.4. Enzyme purification 
Threonine deaminase was purified approx. 60-fold 
from crude extracts, representing 1300-fold purifica- 
tion over the activity of wild type extracts. The purifi- 
cation procedure is identical to that described by Burns 
and Zarlengo [ 1 l] for the enzyme from Salmonella 
[il~(M*lO’)or [Ma-ile] and Co-me-th~(ltl.10’) 
Fig. 1. Inhibition of threonine deaminase activity by isoleucine 
(ile: o-o-o), 0-methyl-threonine (0-me-thr: a-o-o), 
thiaisoleucine (thia-tie: o-o-e). Each assay was performed 
with 0.94 c(g of purified enzyme. 
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typhymurium and includes column chromatography 
on DEAE-cellulose and hydroxylapatite. The enzyme 
fractions from the hydroxylapatite column were pool- 
ed and dialyzed against 0.05 M potassium phosphate 
pH 7.4, containing 8 X 1tJ4 M L-isoleucine, 5 X 1CJ4 
M EDTA and 5 X 1 (r4 M Cleland’s reagent and stored 
at -20’. 
Table 2 shows results of a typical purification. The 
purified enzyme preparation shows a negligible oxida- 
tion of NADH when no threonine is present (less than 
0.6%). Although this is the best preparation to our 
knowledge described in the literature for threonine 
deaminase from E. coli, it is probably far from being 
pure. 
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Fig. 2. Substrate saturation curves. In fig. 2A threonine deam- 
inase activity is reported as a function of threonine concentra- 
tion without inhibitors (e-o--@) or in presence of 0.05 mM 
isoleucine (o-o-o), or in the presence of 5 mM O-methyl- 
threonine (@-o--o) or in the presence of 2.5 mM thiaiso- 
leucine (e-e-e). Each assay was performed with 0.94 pg 
of purified enzyme. The same data are plotted as the reciprocal 
activity vs the reciprocal threonine concentration in fig. 2B. 
Fig. 2C shows Hill’s plots [ 12, 131 of the dependence of en- 
zyme activity upon threonine concentration. For symbols 
see text. 
3. Results and discussion 
The inhibition of threonine deaminase activity by 
isoleucine, 0-methyl-threonine and thiaisoleucine is 
shown in fig. 1; concentrations at which 50% inhibition 
is achieved are 0.14 mM for isoleucine, 25 mM for Q- 
methyl-threonine, and 7.5 mM for thiaisoleucine; Ki’s 
were not calculated because Lineweaver and Burk’s 
plots were not linear (see fig. 2B). 
The inhibitory effect of isoleucine, O-methyl-threon- 
ine and thiaisoleucine was also studied as a function of 
substrate concentration and the results are shown in 
fig. 2A. It appears that isoleucine increases the sigmoid 
character of the saturation curve of enzyme with re- 
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spect to the substrate; O-methyl-threonine and thia- 
isoleucine do not show this effect and therefore they 
should not be considered allosteric inhibitors. In fig. 
2B the same data are plotted as reciprocal enzyme ac- 
tivity vs reciprocal substrate concentration. As expect- 
ed, the experimental points obtained with no inhibi- 
tors do not fit a straight line since the enzyme prepa- 
ration used contains isoleucine (final cont. in these 
assays: 1 X 1CJ6M, see Materials and methods). Addi- 
tion of isoleucine increases the deviation from linear- 
ity in agreement with previously published data [3] 
while 0-methyl-threonine and thiaisoleucine do not 
show this effect. 
In fig. 2C data of the substrate saturation curves 
are plotted as log --“; 
K 
against log [threonine] in or- 
der to determine t e apparent order of the reaction 
with respect to the substrate, either in the absence of 
effecters, or in the presence of the allosteric inhibitor 
isoleucine, or in the presence of one of the two other 
inhibitors 0-methyl-threonine and thiaisoleucine, ac- 
cording to the following equation 
log - 
V-“V 
= log K t n log [threonine] 
(where V = activity (v) in the presence of saturating 
substrate) [ 12, 131. The order of the reaction n for 
the substrate is equal to 1.6 when no inhibitors are 
present; in the presence of isoleucine it increases to a 
value of 2.4, while it does not increase in the presence 
of 0-methyl-threonine (n = 1.3) or thiaisoleucine (n = 
1.2). Thus these values of n support the conclusion 
that 0-methyl-threonine and thiaisoleucine are com- 
petitive inhibitors of threonine deaminase. If this con- 
clusion is correct it should be possible to confirm it 
by the use of the other allosteric effector, valine: it 
has been reported, indeed, that isoleucine inhibition of 
threonine deaminase is counteracted by the other 
allosteric effector valine [3]; if O-methyl-threonine and 
thiaisoleucine are isosteric inhibitors their inhibition 
should not be counteracted by valine. Fig. 3 shows that 
valine is able to remove isoleucine inhibition, but not 
the inhibition caused by 0-methyl-threonine and thia- 
isoleucine. 
0-methyl-threonine and thiaisoleucine appear to 
interact at the active site of threonine deaminase. Un- 
published evidence suggesting the same conclusion for 
thiaisoleucine has been reached by Dr. H.E. Umbarger 
(personal communication). Evidence confirming this 
2Sr - - 
0 
Fig. 3. Effect of valine on the inhibition of threonine deam- 
inase activity exerted by isoleucine, 0-methyl-threonine of 
thiaisoleucine. (e-o-o): control (no inhibitor added); 
(o-o-o): 0.2 mM isoleucine; (e-@--@): 40 mM O- 
methyl-threonine; (o-e-o): 10 mM thiaisoleucine. Each 
assay was performed with 0.94 pg of purified enzyme. 
conclusion for 0-methyl-threonine has been reported 
by Smulson et al. [l] who showed that when threo- 
nine deaminase in extracts of E. cob 15 is treated with 
Hg2’ it becomes insensitive to isoleucine but it is still 
inhibited by 0-methyl-threonine. It is possible to con- 
clude, therefore, that 0-methyl-threonine and thia- 
isoleucine behave as threonine analogues in the case 
of this enzyme. On the other hand these two substan- 
ces behave as isoleucine analogues in other systems. 
It has been reported, in fact, that O-methyl-threonine 
and thiaisoleucine behave as substrates for isoleucyl- 
tRNA synthetase either extracted from E. coli 15 [l] 
or E. coli K-l 2 [2] or purified from E. coli K-12 [ 141; 
they also inhibit the active transport of valine into 
E. coli K-12 (Guardiola, Klopotowski and Iaccarino, 
unpublished experiments) while thiaisoleucine inhibits 
the transamination of isoleucine [2]. It is apparent 
therefore that the definition of analogue of a certain 
natural product is related to the enzyme or system 
tested. 
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